Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2016 April;107(2)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

 

Minerva Medica 2016 April;107(2)

     REVIEWS

Minerva Medica 2016 April;107(2):77-83

Long noncoding RNA ANRIL: a potential novel prognostic marker in cancer: a meta-analysis

Fang T. LIU, Pei Q. ZHU, Hong L. LUO, Yi ZHANG, Teng F. HAO, Guang F. XIA, Zheng M. ZHU, Cheng QIU


Minerva Medica 2016 April;107(2):84-91

Positive association between IL-16 rs1131445 polymorphism and cancer risk: a meta-analysis

Fang T. LIU, Pei Q. ZHU,Yang X. OU, Wan W. LIU, Guang F. XIA, Hong L. LUO


Minerva Medica 2016 April;107(2):92-100

Quantitative assessment of the association between interleukin-10 promoter gene polymorphisms and nasopharyngeal carcinoma susceptibility

Haohai HUANG, Yongfu WU, Dan LIAO, Hanbin ZHANG


Minerva Medica 2016 April;107(2):101-7

Long non-coding RNA-LET can indicate metastasis and a poor prognosis: a meta-analysis

Fang T. LIU, Pei Q. ZHU, Yang X. OU, Quan S. LIN, Cheng QIU, Hong L. LUO


Minerva Medica 2016 April;107(2):108-13

Alzheimer’s Disease therapeutics: current and future therapies

Lin B. GAO, Xiao F. YU, Qin CHEN, Dong ZHOU


Minerva Medica 2016 April;107(2):114-22

Fentanyl citrate sublingual formulation (Vellofent®) for quick BTcP hindering

Patrizia ROMUALDI, Sanzio CANDELETTI


     LETTERS TO THE EDITOR

Minerva Medica 2016 April;107(2):123-4

Heme oxygenase-1 in type 2 diabetes: from cell first-line defense to early marker of diabetic nephropathy

Elisa PAGNIN, Giuseppe MAIOLINO, Lorenzo A. CALÒ


Minerva Medica 2016 April;107(2):124

Two considerations on analgesic gastrointestinal tolerance

Rinaldo PELLICANO, Giovanni C. ACTIS, Giorgio M. SARACCO


top of page